SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Monday reported a loss of $31.7 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of $1.17.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.31 per share.
The drugmaker posted revenue of $4.4 million in the period.
La Jolla Pharmaceutical shares have decreased slightly more than 9% since the beginning of the year. In the final minutes of trading on Monday, shares hit $8.54, a decline of 72% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LJPC at https://www.zacks.com/ap/LJPC